These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34628459)

  • 21. Mesenchymal stromal cells for systemic sclerosis treatment.
    Farge D; Loisel S; Lansiaux P; Tarte K
    Autoimmun Rev; 2021 Mar; 20(3):102755. PubMed ID: 33476823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paquinimod reduces skin fibrosis in tight skin 1 mice, an experimental model of systemic sclerosis.
    Stenström M; Nyhlén HC; Törngren M; Liberg D; Sparre B; Tuvesson H; Eriksson H; Leanderson T
    J Dermatol Sci; 2016 Jul; 83(1):52-9. PubMed ID: 27156795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic sclerosis: Update for oral health care providers.
    Alhendi FJ; Werth VP; Sollecito TP; Stoopler ET
    Spec Care Dentist; 2020 Sep; 40(5):418-430. PubMed ID: 33448431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An update on biomarker discovery and use in systemic sclerosis.
    Matsushita T; Takehara K
    Expert Rev Mol Diagn; 2017 Sep; 17(9):823-833. PubMed ID: 28730919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolving insights into the cellular and molecular pathogenesis of fibrosis in systemic sclerosis.
    Korman B
    Transl Res; 2019 Jul; 209():77-89. PubMed ID: 30876809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic Sclerosis Pathogenesis and Emerging Therapies, beyond the Fibroblast.
    Sierra-Sepúlveda A; Esquinca-González A; Benavides-Suárez SA; Sordo-Lima DE; Caballero-Islas AE; Cabral-Castañeda AR; Rodríguez-Reyna TS
    Biomed Res Int; 2019; 2019():4569826. PubMed ID: 30809542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Animal models of systemic sclerosis.
    Morin F; Kavian N; Batteux F
    Curr Pharm Des; 2015; 21(18):2365-79. PubMed ID: 25777753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of the suction device Nimble for the assessment of skin fibrosis in systemic sclerosis.
    Müller B; Ruby L; Jordan S; Rominger MB; Mazza E; Distler O
    Arthritis Res Ther; 2020 Jun; 22(1):128. PubMed ID: 32493508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology and risk factors for pulmonary hypertension in systemic sclerosis.
    Yaqub A; Chung L
    Curr Rheumatol Rep; 2013 Jan; 15(1):302. PubMed ID: 23292818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic sclerosis: Is the epithelium a missing piece of the pathogenic puzzle?
    Asano Y; Takahashi T; Saigusa R
    J Dermatol Sci; 2019 May; 94(2):259-265. PubMed ID: 31079997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis.
    MacDonald KG; Dawson NAJ; Huang Q; Dunne JV; Levings MK; Broady R
    J Allergy Clin Immunol; 2015 Apr; 135(4):946-955.e9. PubMed ID: 25678090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic sclerosis.
    Denton CP; Khanna D
    Lancet; 2017 Oct; 390(10103):1685-1699. PubMed ID: 28413064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The
    Kavian N; Mehlal S; Jeljeli M; Saidu NEB; Nicco C; Cerles O; Chouzenoux S; Cauvet A; Camus C; Ait-Djoudi M; Chéreau C; Kerdine-Römer S; Allanore Y; Batteux F
    Front Immunol; 2018; 9():1896. PubMed ID: 30177933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrosis Development in HOCl-Induced Systemic Sclerosis: A Multistage Process Hampered by Mesenchymal Stem Cells.
    Maria ATJ; Toupet K; Maumus M; Rozier P; Vozenin MC; Le Quellec A; Jorgensen C; Noël D; Guilpain P
    Front Immunol; 2018; 9():2571. PubMed ID: 30455706
    [No Abstract]   [Full Text] [Related]  

  • 35. How I treat patients with systemic sclerosis in clinical practice.
    Rossi D; Zanatta E; Marson P; Sciascia S; Polito P; Roccatello D; Cozzi F
    Autoimmun Rev; 2017 Oct; 16(10):1024-1028. PubMed ID: 28778710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations of right ventricular myocardial function with skin and pulmonary involvement in asymptomatic patients with systemic sclerosis.
    D'Andrea A; Bellissimo S; Scotto di Uccio F; Vigorito F; Moscato F; Tozzi N; Di Donato M; Citro R; Stisi S; Scherillo M
    Ital Heart J; 2004 Nov; 5(11):831-9. PubMed ID: 15633438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of skin fibrosis in systemic sclerosis.
    Jinnin M
    J Dermatol; 2010 Jan; 37(1):11-25. PubMed ID: 20175837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis.
    Nihtyanova SI; Sari A; Harvey JC; Leslie A; Derrett-Smith EC; Fonseca C; Ong VH; Denton CP
    Arthritis Rheumatol; 2020 Mar; 72(3):465-476. PubMed ID: 31682743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic sclerosis: one year in review 2022.
    Lepri G; Orlandi M; Di Battista M; De Mattia G; Da Rio M; Codullo V; Guiducci S; Della Rossa A
    Clin Exp Rheumatol; 2022 Oct; 40(10):1911-1920. PubMed ID: 36135958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A possible contribution of altered cathepsin B expression to the development of skin sclerosis and vasculopathy in systemic sclerosis.
    Noda S; Asano Y; Akamata K; Aozasa N; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
    PLoS One; 2012; 7(2):e32272. PubMed ID: 22384200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.